Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
58.59
+0.29 (0.50%)
At close: Jul 15, 2026
Market Cap7.86B +84.7%
Revenue (ttm)323.87M -40.8%
Net Income89.82M -54.2%
EPS0.66 -54.1%
Shares Out 134.87M
PE Ratio88.36
Forward PE62.69
Dividend0.45 (0.77%)
Ex-Dividend DateJun 16, 2026
Volume1,807,302
Open57.83
Previous Close58.30
Day's Range57.26 - 60.99
52-Week Range29.99 - 68.50
Beta1.10
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic products. It offers Covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test and TORCH test, neurological testing and hepatitis test, as well as tropical disease test such as neurological testing. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 571
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 144.47 million, a decrease of -41.48%.

Financial Statements